trending Market Intelligence /marketintelligence/en/news-insights/trending/OQgsG55f1OaDXPRItJ5Byg2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

ReShape Lifesciences to be delisted from Nasdaq


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates

ReShape Lifesciences to be delisted from Nasdaq

ReShape Lifesciences Inc. said Nasdaq has determined to delist the company's shares from the stock exchange Dec. 31.

The decision is based on ReShape Lifesciences' failure to regain compliance with the exchange's $1 minimum bid price requirement.

The San Clemente, Calif.-based medical device company also failed to inform the exchange of its intent to list additional shares, another listing requirement.

ReShape Lifesciences stocks will now trade on the OTC Markets under the symbol RSLS.